Sorafenib-Loaded Cu<sub>2−x</sub>Se Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma

Sorafenib-Loaded Cu<sub>2−x</sub>Se Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) accounts for the predominant form of liver malignancy and presents a leading cause of cancer-related death globally. Sorafenib (SOR), a first-line targeted drug for advanced HCC treatment, has a battery of untoward side effects. Photothermal therapy (PTT) has been util...

Full description

Bibliographic Details
Main Authors: An-Tian Huang, Jun Du, Zhi-Yong Liu, Guang-Cong Zhang, Weinire Abuduwaili, Jia-Yan Yan, Jia-Lei Sun, Ru-Chen Xu, Tao-Tao Liu, Xi-Zhong Shen, Ling Dong, Ji-Min Zhu, Yuhao Li
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Nanomaterials
Subjects:
sorafenib
hepatocellular carcinoma
copper(I) selenide
photothermal therapy
synergistic therapy
Online Access:https://www.mdpi.com/2079-4991/12/18/3191

Internet

https://www.mdpi.com/2079-4991/12/18/3191

Similar Items